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Abstract 
 In recent years in the Republic of Macedonia, the pharmaceutical legislation has 
undergone permanent modifications in terms of the unification with the European legislation. 
In essence, the establishment of certain new criteria and the amendment of the whole set of 
standards uniform in the EU, will undoubtedly help in increasing the quality of 
pharmaceutical services and will guarantee the patients’ health. The Republic of Macedonia 
has a social healthcare system. Pharmacies are in private ownership but healthcare authorities 
regulate the prices of medications and the number of pharmacies across the whole territory. 
Many of these pharmacies have concluded regular collaboration contracts with the Health 
Insurance Fund of the Republic of Macedonia. The services provided by these pharmacies 
consist mainly in the distribution of prescribed medications and OTC preparations, nutrition 
products, medication usage recommendations, effects and anti-effects, etc. This paper aims at 
reviewing the existing legislation, the reforms carried out in time, the existing status of the 
pharmaceutical community in Macedonia, while comparing it with some of the countries of 
the EU. Special emphasis will be put on reviewing the possibilities for better inclusion of 
pharmacists in the healthcare system so that they can become participants in the healthcare 
provision teams as well as get included in the activities for the prevention of different 
diseases. In this respect, lots of research in international literature, including scientific articles, 
presentations, technical reports, and other studies has been carried out in order to present the 
experiences from the EU member states. 
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Introduction 
 Changes in the nation’s health care system, especially the growth of managed care and 
integrated health systems, are stimulating adoption of primary care as a way of meeting basic 
health care needs and managing access to specially services. Integrated health systems are 
organized to deliver acute, intermediate, long-term, home, and ambulatory care. They are 
intended to seamlessly provide care across practice settings through appropriate use of 
individual health professionals and team (Am.J.Health-Syst Pharm. 1996). 
 Pharmacy has matured as a clinical profession and is presently well positioned to 
transform itself from product and ask oriented (dispensing) to a patient oriented profession 
(provision of care, advice and counseling) (Adepu R. et al, 2006). One of the key factors of 
the improvement of healthcare services are the pharmacists. Their role is crucial since the 
profession of a pharmacist in itself means having to deal with patients with different needs on 
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daily basis, who quite often require more qualitative healthcare services and treatment. 
 Pharmaceutical care is a practice philosophy for pharmacy. It is the way of 
pharmacists to coach the individual patients with their medication. The concept deals with the 
way a patient should receive and use medication and should receive education on the use of 
medicines. The concept also deals with responsibilities, medication surveillance, counseling 
and the evaluation of all the outcomes of care (Foppe van Mil JW et al.2004).  In many 
developed countries of the EU such as Germany, Austria, Denmark, Portugal, and United 
Kingdom, community pharmacists are involved in many dimensions in healthcare. 
Pharmacists in these countries also participate in disease management. On the contrary, in the 
 Republic of Macedonia, even though the concept on the pharmaceutical care is one of 
the most important items within the framework of great changes that have been made in the 
pharmaceutical sector, the services provided by community pharmacists usually consist of 
medicine dispensing and limited medication advice. 
 
Materials and Methods  
 There has been a lot of research carried out based on international literature such as 
scientific articles, abstracts, presentations, technical reports and other studies that deal with 
the issue of inclusion of pharmacists in the healthcare systems. The guidelines of Good 
Pharmacy Practice (GPP) have also been used. At the center of attention there have been 
articles which deal with pharmaceutical services provided by the pharmaceutical community 
in some of the EU countries, which were selected as points of reference. The comparison was 
made based on the existing situation of the pharmaceutical community in Macedonia. Based 
on the analyzed data, recent changes within the framework of numerous reforms in the 
pharmaceutical sector I particular and the healthcare system in general, were selected. The 
data related to the number of pharmacies per capita and the services provided by pharmacies 
have been given in charts using MS Excel 2007. Comparative data from some EU countries 
have also been presented in graphs.  
 
Results  
Historical reforms in the pharmaceutical sector in Macedonia 
 Since 1991 the pharmaceutical sector in Macedonia has undergone drastic and 
permanent changes due to the fact that all healthcare institutions including pharmacies 
experienced a transition from the public to the private system. The pharmaceutical community 
increased permanently. With the establishment of private pharmacies, there was a need for 
change in the legislation. In the coming years, within the numerous reforms the establishment 
of a National Drug Information Centre in 1998 happened. In addition, a National Centre for 
Pharmacovigilance was established in 1991. In 1997, it was networked with the WHO Center 
Drug Adverse Effects as accompany member, while full membership was obtained in 2000  
(Petrushevska-Tozi L. et al, 2012). The reforms at a broader level in the healthcare system 
would include the implementation of new norms of Good Pharmacy Practice (GPP) in 2009. 
 The GPP guidelines define four core activities of pharmacists: 1) public health 
function related to health promotion and disease prevention 2) supply of medicines and 
medical products of good quality as well as provision of relevant patient instructions and 
advice on medicine use 3) self-medication activities and related patient advice and 4) 
pharmacist contribution to rational prescribing and appropriate use of medicines (Official 
Gazette of RoM, No.44, 2009). This would create the possibility for improving quality of 
pharmaceutical services and the inclusion of pharmacists in many roles in terms of healthcare 
and it would also ensure them the deserved place in the overall community of healthcare 
providers and workers. The great enthusiasm that emerged within the pharmaceutical 
community was soon put out since other problems started to appear and they were most often 
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related to the economic aspect as well as the lack of coordination with the existing legislation, 
which does not support the concepts of pharmaceutical practice and care . 
 
The current status of the pharmaceutical community and future challenges  
 There are 740 pharmacies that are currently active in Macedonia, along with another 
44 installed within the secondary and tertiary level healthcare institutions (Official Gazette of 
RoM, No. 81, 2012). In total, the proportion of pharmaceutical communities and the 
population is 1:2500. In the presented graphs below, we can see the great differences when 
compared to some EU countries such as Germany, Austria, Denmark, United Kingdom, 
Portugal, Finland, Netherlands, etc. This is because in these countries there is another mode of 
organization of the pharmaceutical community. In some countries pharmacies are large and 
they offer services for a great community and in some other countries there are more small 
pharmacies that provide services to a certain number of inhabitants. The Scandinavian type of 
pharmacy has relatively large pharmacies, serving 10.000-18.000 people. Southern Europe, 
France and Belgium have very small pharmacies that serve approximately 2000-2500 clients. 
 In the UK and Ireland are Anglo-Saxon type pharmacies which sell many non- 
medical items in addition to medicines and which serve approximately 3500 people. Lastly, 
there are pharmacies in Central and Eastern Europe (Germany, Switzerland, Austria), which 
focus on all kinds of healthcare amenities and serve 3000-5000 people (J.W.Foppe et al. 
2006) 
Fig. 1 Number of population pharmacy and community pharmacy in some EU countries 
 
 Source: Atkinson J, Rombaut B. The 2011 PHARMINE report on pharmacy and pharmacy 
education in the European Union. Pharmacy Practice (Internet) 2011 Oct-Dec;9(4):169-187.  
 What should be pointed out is the fact that these pharmacies have been distributed 
irrationally. A greater concentration of pharmacies can be noticed in main centers and towns, 
whereupon in some cases their number exceeds the maximal necessary amount. On the other 
hand, in some rural areas there may be cases where there are no pharmacies at all, which is a 
big hassle to the population residing in these areas. Since all pharmacies are private in terms 
of primary healthcare, there are no mechanisms to facilitate the establishment of new 
pharmacies in these areas, since the owners are led by their economic interests (Farmac. 
Informator, 2010). 
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Tab 1. Network of community pharmacies per regions in Republic of Macedonia 
 
 In general they are small pharmacies in which higher school graduate pharmacists 
work (at least one pharmacist per shift who as to be on site all the time) and a technician who 
have usually graduated from professional medical/pharmaceutical high schools (Official 
Gazette of RoM, No.11, 2012). Services offered by pharmacists in these pharmacies are still 
limited to medication delivery, information of patients about the effects of drugs, etc. This 
situation changes a lot in developed countries of the EU where the role of pharmacists is 
multidimensional and the services offered by the pharmaceutical community encompass a 
broader array.  
 Based on the experience form some of the developed countries, the role of pharmacists 
according to the Standards for Quality Pharmacy Services (GPP) is as follows: “Pharmacists 
should engage in preventive care activities that promote public health and prevent disease, i.e. 
in areas such as smoking cessation, infectious and sexually transmitted diseases; pharmacists 
should also provide point-of-care testing, where applicable, and other health screening 
activities for patients at higher risk of disease”  (WHO Technical Report Series, 2011). There 
have been many attempts by the Macedonian Pharmacist Association for better inclusion of 
pharmacists in the healthcare sector but they have all resulted in failure. Such attempts have 
never been supported by the Ministry of Health and as such they remain a challenge for the 
future.  
 
A review of pharmaceutical care in some European countries  
  In different European countries, one can notice a difference between the modes of 
organization of the pharmaceutical community since in line with their regulations and 
legislation, as well as the healthcare system, these countries have guided and developed the 
pharmaceutical practice in different directions.  
 In the UK, National Health Service (NHS) pharmaceutical services are delivered under 
contract by privately owned community pharmacies. Community pharmacies in UK have a 
crucial role in primary care and public health; there are also several examples of community 
pharmacy involvement in chronic disease management. In the North-East Primary Care Trust 
Hospital, patient hospital discharge information concerning high-risk patients is faxed to 
community pharmacists. The pharmacist visits the person at home for medication review, 
liaises with the GP practice, produces a care plan and continues to monitor progress/control 
(Noyce PR, 2007). 
 In Germany, cognitive pharmaceutical services are being implemented and the role of 
pharmacists only supplying medicines is changing. In 2003 the way towards cognitive 
Region location of 
community pharmacy 
Actual  
number* 
Maximum  
number** Citizens (total) 
Macedonia 740 617 1850190 
Pelagonia 107 77 234137 
Vardar 54 43 133106 
North-East 57 58 175045 
South-West 70 74 221855 
Skopje 233 207 619718 
South-East 76 59 172858 
Polog 76 106 314804 
East 67 67 200522 
Source: Regulation for Network of Health Institutions (Official Gazette of RM, No. 
81/12) 
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pharmaceutical services started with family pharmacy contracts between community 
pharmacists representatives and the largest sickness fund that include remuneration of 
pharmacists when providing pharmaceutical care. These contracts were extended in 2004 and 
since then general practitioners have been integrated. Most of the community pharmacies in 
Germany are part of this initiative (Eickoff C.et al, 2006). 
 In Portugal, there are 2,549 pharmacies, a coverage ratio of 4,692 inhabitants per 
pharmacy. The community pharmacist in Portugal makes an active contribution to the 
adoption of healthy habits and the prevention of illness, making the pharmacy a place of 
health care that plays an increasingly active role in the rational use of medicines and in 
promoting the well-being of the population. Indeed, the pharmacist plays a most active role in 
promoting the rational use of medicines, in pharmaco-surveillance, in health education, in 
detecting certain disease, in fight against AIDS, and in providing information both to doctors 
and to patients   
 Given the degree of confidence and credibility which the pharmacists inspires among 
the population, and the ease of dialogue between pharmacist and patient, several education 
campaigns have been successfully promoted, aimed at health care and at the prevention and 
detection of disease (Ilvana .S, 2001). 
 Denmark has 322 pharmacies, corresponding to one pharmacy per 16,700 inhabitants. 
All pharmacies provide prescription and over-the-counter products, advice about medicine 
use, dose dispensing, generic substitutions, and administration of individual reimbursement 
registers. Except for very simple processes, compounding is centralized at three pharmacies. 
Many pharmacies offer measurement of blood glucose, blood pressure, and cholesterol, and 
60% offer inhalation counseling, a reimbursed service (Hanne H. et al, 2007). 
 In the Netherlands, where pharmacies are relatively big and 95% of patients always 
visit the same pharmacy, medication surveillance (automated drug use review or DUR) 
developed as early as the 1980s, and pharmacists and general practitioners (GPs) in the region 
discuss pharmacotherapy almost monthly (de Smet  PAGM, 1992). Pharmaceutical care 
standards were first established in 1996, and the scientific institute  of the professional 
pharmacist organization (WINAP) chose pharmaceutical care as its focus for further 
professional development around 1997 (Boysen M, 2004). In general, the comprehensive 
pharmaceutical care model is followed, although a number of disease-oriented projects 
addressing asthma and diabetes have also been implemented (Blom LTG et al. 1999)  
 Finland had 799 community pharmacies as of 2005. Medication counseling has been 
mandated by law since 1983 and only pharmacists are permitted to provide therapeutic advice 
in pharmacies. Since the late 1990s, Finish pharmacies have actively participated in national 
public health programs, initially in the areas of asthma and diabetes, and more recently in the 
treatment and prevention of heart disease (Bell JS et al. 2007). 
 
Conclusion 
 Numerous studies that have been carried out in recent years in almost all European 
countries speak about different forms of inclusion of pharmacists in the healthcare system. In 
many of these countries, the implementation of GPP norms and the inclusion of pharmacists 
with a multidimensional role is giving promising results both in the treatment and prevention 
of many illnesses. Pharmacists represent a very important part in the healthcare system since 
they are the ones to detect, prevent or correct the problems that their patients face. In 
Macedonia there is sufficient potential and workforce and readiness by pharmacists to 
undertake new roles in the healthcare system as a whole. The experiences from the countries 
included in this study should serve as a motivation for the Ministry of Health to start thinking 
about including pharmacists in the adopted health care programs. In addition, the correctness 
in relations between physicians and pharmacists remains as one of the challenges to be dealt 
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with in the future, since its final resolution would actually mean better healthcare services for 
the patients. 
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